LENSAR Inc
NASDAQ:LNSR

Watchlist Manager
LENSAR Inc Logo
LENSAR Inc
NASDAQ:LNSR
Watchlist
Price: 7.38 USD -0.94% Market Closed
Market Cap: 85.7m USD
Have any thoughts about
LENSAR Inc?
Write Note

LENSAR Inc
Other Non-Cash Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LENSAR Inc
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
LENSAR Inc
NASDAQ:LNSR
Other Non-Cash Items
$9m
CAGR 3-Years
-2%
CAGR 5-Years
114%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Other Non-Cash Items
-$46m
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Other Non-Cash Items
$676m
CAGR 3-Years
322%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Other Non-Cash Items
$313m
CAGR 3-Years
-25%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
Abbott Laboratories
NYSE:ABT
Other Non-Cash Items
$802m
CAGR 3-Years
-9%
CAGR 5-Years
0%
CAGR 10-Years
12%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Non-Cash Items
$604.6m
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
12%
No Stocks Found

LENSAR Inc
Glance View

Market Cap
85.2m USD
Industry
Health Care

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 110 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company has developed the LENSAR Laser System to provide an alternative laser cataract treatment tool that allows the surgeon to better address astigmatism and improve visual outcomes. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The company is also developing an integrated cataract treatment system, ALLY, which is designed to combine its existing femtosecond laser technology with phacoemulsification system into a single unit and allow surgeons to perform each of the critical steps in a cataract procedure in a single operating room using this device.

LNSR Intrinsic Value
8.59 USD
Undervaluation 14%
Intrinsic Value
Price

See Also

What is LENSAR Inc's Other Non-Cash Items?
Other Non-Cash Items
9m USD

Based on the financial report for Dec 31, 2023, LENSAR Inc's Other Non-Cash Items amounts to 9m USD.

What is LENSAR Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
114%

Over the last year, the Other Non-Cash Items growth was 24%. The average annual Other Non-Cash Items growth rates for LENSAR Inc have been -2% over the past three years , 114% over the past five years .

Back to Top